We previously discovered that PC-derived S100A9 could induce insulin resistance by inhibiting insulin-stimulated glucose uptake in muscle cells and thereby led to PCDM [16], a paraneoplastic phenomenon occurring in approximately 50% of PC patients within 24 months before the diagnosis of cancer [34]. This evidence concerns the gene S100A9 and cancer.